Calamos Advisors
VANI icon

Calamos Advisors’s Vivani Medical VANI Stock Holding History

Calamos Advisors’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-550
Closed -$17K – 652
2017
Q2 		$17K Hold
550
– – ﹤0.01% 606
2017
Q1 		$16K Buy
550
+133
+32% +$5.09K ﹤0.01% 614
2016
Q4 		$20K Hold
417
– – ﹤0.01% 632
2016
Q3 		$35K Buy
+417
New +$36.9K ﹤0.01% 598

Other funds holding VANI

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VDBMI
Van Den Berg Management I Austin, Texas $436M AUM 40.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CD
Carl Domino West Palm Beach, Florida $82M AUM 19.36% 1-Year Est. Return

Calamos Advisors's VANI Position: Q3 2017 in Review

Calamos Advisors sold out of Vivani Medical (VANI) in Q3 2017, closing a stake of 550 shares — an estimated $17K sold.

Calamos Advisors first reported a position in VANI in Q3 2016 and held it in 4 quarters. The position peaked at $35K in Q3 2016. 43 funds tracked by Wall St. Rank hold VANI as of Q3 2017.

  • Calamos Advisors reported no remaining Vivani Medical position as of Q3 2017 after selling out during the quarter.
  • Calamos Advisors sold 550 Vivani Medical shares in Q3 2017, an estimated $17K.
  • Calamos Advisors first reported a position in Vivani Medical in Q3 2016 and held it in 4 quarters.
  • Calamos Advisors's Vivani Medical position peaked at $35K in Q3 2016.
  • 43 funds tracked by Wall St. Rank held Vivani Medical as of Q3 2017.

Based on Calamos Advisors's 13F filing for Q3 2017, filed 25 Oct 2017.